商家希望创造利润、政府想要削减开支、消费者希望有物美价廉的选择,仿制药和零售自有品牌药成为亚洲市场的新宠。全球范围内,高企的医疗支出和人口老龄化成为让政府头疼的事情,降低医疗费用的诉求非常强烈。与此同时,政府尽可能将医疗保健开支的重负转嫁到个人头上,而当消费者需要为自身的健康买单之际,价格成为非常重要的考虑因素。 Businesses want to create profits, the government wants to cut spending, consumers want cheap and affordable options, generic drugs and retail private label drugs to become the new darling of the Asian market. Globally, the high medical expenses and the aging population have become a headache for the government. The demand for reducing medical expenses is very strong. In the meantime, the government has shifted the burden of health care spending to individuals as much as possible, and price becomes a very important consideration as consumers pay for their own health.